Roundup: Non-OTC drugs prescription via telemedicine prohibited in India and more briefs
25 Aug 2023
Regulator bars e-prescription of non-OTC drugs in India
Indian doctors using telemedicine can only prescribe OTC Drugs, according to the National Medical Commission.
Based on the medical profession regulator's
latest rules of professional conduct of registered medical practitioners in the country, doctors cannot prescribe via telemedicine drugs classified under Schedule X of the Drug and Cosmetic Act, including anti-cancer drugs.
The regulations also frown upon medical practitioners who insist on conducting telemedicine when a patient is willing to travel to a health facility and/or requests an in-person consultation.
Meanwhile, the new regulations order doctors to keep digital records, such as patient records, reports, and images, for three years from their patient's last consultation.
Hong Kong's Health Department to hasten public health digitalisation
The Hong Kong Department of Health has recently tied up with technology incubator Hong Kong Science and Technology Parks Corporation to pursue public health digitalisation.
Under their memorandum of understanding, they will explore innovative solutions in four areas: health regulatory affairs, health protection and health promotion, health administration, and dental and clinical services.
To this end, they will be working on six public health application areas: smart health regulatory functions, smart clinics, smart workflow re-engineering, smart customer services, online engagement, and data collaboration.
Their pursuit of new solutions will also allow tech ventures to test their tailor-made solutions in real-life operating settings.
UMP to rollout Imsight's AI-assisted CXR analysis tool
Hong Kong-listed medical group UMP will soon offer AI-powered medical imaging analysis.
The company recently signed a memorandum of understanding with Imsight Technology to deploy the DR-Sight medical imaging solution to its centres in Hong Kong, Macau, and Mainland China.
The AI-powered technology provides diagnostic support for analysing chest X-rays. It can identify various chest findings, including pneumonia, tuberculosis, pulmonary oedema, and pneumothorax. It is also capable of alerting doctors of suspicious findings, which then enables early interventions.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.